Nov 2026· Diagnostics· Vol 16· 0 citations· 30 references
Medicine
TL;DR
It is found that serum IL-12 levels were associated with interferon-γ levels and rheumatoid factor positivity in patients with RA, supporting a role for IL-12 at the interface between cellular and humoral immunity.
Abstract
Background: IL-12 is a proinflammatory cytokine produced mainly by activated dendritic cells and macrophages that drives the differentiation of naïve T cells into Th1 cells and stimulates interferon-γ production by natural killer and T cells, thereby linking innate and adaptive immunity. Ultrasensitive quantification of IL-12 has not previously been performed in large rheumatoid arthritis (RA) cohorts, mainly due to the limited availability and high cost of these platforms. In the present study, we measured serum IL-12 using an ultrasensitive assay to systematically assess its relationship with key disease characteristics in a large, well-characterized cohort of patients with RA. Methods: A total of 216 patients with RA were recruited and underwent a comprehensive assessment of disease characteristics and disease activity. Lipid parameters and hematological markers were assessed, insulin resistance indices were calculated, and metabolic syndrome was defined according to established criteria. Arterial stiffness, carotid intima-media thickness, and plaque presence were evaluated through carotid ultrasonography. Serum IL-12 levels were quantified using Simoa (Single Molecule Array) technology. To examine the relationship between clinical and metabolic parameters and IL-12 concentrations, multivariable linear regression models were applied. Results: In multivariable analyses, serum IL-12 levels were independently associated with IFN-γ and rheumatoid factor positivity. However, no significant relationships were found between IL-12 and disease activity indices, acute-phase reactants, cardiovascular risk factors, subclinical atherosclerosis, lipid profile, glucose metabolism, or hematological parameters. Conclusions: Using an ultrasensitive assay, we found that serum IL-12 levels were associated with interferon-γ levels and rheumatoid factor positivity in patients with RA, supporting a role for IL-12 at the interface between cellular and humoral immunity. In contrast, circulating IL-12 did not appear to be a useful systemic biomarker of disease activity or of the cardiovascular and hematological comorbidities associated with RA.
IL-38 is associated with disease activity, shows no association with HLA-DRB1 expression, and is lower among patients receiving more advanced pharmacological therapy — identifying it as a candidate pharmacodynamic biomarker in RA.
Yasir Chnani, Rafid Abdulkarrem· Egyptian Rheumatology and Re...· 0 citations
Introduction While biologic disease-modifying antirheumatic drugs (bDMARDs) have transformed management, achieving complete remission remains a challenge due to complex immune networks in Psoriatic arthritis (PsA). This study aimed to characterize the functional modulation of circulating T-helper (Th) and cytotoxic T (...
Sibel Goksen, G. Ayan, U. Kalyoncu et al.· Frontiers in Immunology· 0 citations
B cell IFITM2 expression is closely associated with disease activity in SLE and may serve as a potential biomarker to improve the discriminatory performance of anti-dsDNA testing, suggesting that combined assessment of IFITM2 and UTP may help reflect renal status in patients with SLE.
Bin Wen, Xiao-Cui Wang, Xue-Mei Duan et al.· Biomedicines· 0 citations
Since IL-13 was associated with an adverse lipid profile, its inverse relationship with augmentation index suggests that its cardiovascular effects may be at least partially independent of circulating lipids.
I. Ferraz-Amaro, J. C. Quevedo-Abeledo, B. Tejera-Segura et al.· BMC Rheumatology· 0 citations
Immune-mediated inflammation plays a central role in atherosclerosis and clinical progression of ischemic heart disease (IHD). The balance between pro-inflammatory and regulatory immune pathways remains incompletely characterized in different coronary syndromes. This study investigated circulating interleukin-35...
R. Alshehristani, H. Hassan, D. Mohammad· European Heart Journal· 0 citations
Growth differentiation factor-15 (GDF-15), also known as macrophage inhibitory cytokine-1, is a member of the transforming growth factor-beta superfamily involved in macrophage regulation. Its exact role in inflammation and tissue repair remains unclear.
To evaluate GDF-15 as a biomarker for rheumatoid arthr...
Caroline K. S. Lotfy, Yosra A. Zamzam, D. Nada et al.· Tanta Medical Journal· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.